Mid-term evolution of Chronic Chagas disease patients hospitalized due to COVID-19
DOI:
https://doi.org/10.59471/ijhsc202138Keywords:
Chagas Disease, COVID-19, SARS-CoV-2, Pneumonia, Arrhythmias, Heart Failure, Trypanosoma CruziAbstract
This is the first report of mid-term evolution of patients with COVID-19 and Chagas Disease (CD). General characteristics, in-hospital evolution, and mid-term follow up of 12 consecutive patients at a single centre is described. A call for action is needed to screen for CD, especially in endemic areas, as the interaction of both diseases may lead to worse cardiac outcomes.
Downloads
References
Echeverría LE, Marcus R, Novick G, Sosa-Estani S, Ralston K, Zaidel EJ, et al. WHF IASC Roadmap on Chagas Disease. Global Heart. 2020; 15(1): 26. DOI: https://doi.org/10.5334/gh.484
Alonso-Padilla J, Cortés-Serra N, Pinazo MJ, et al. Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America. Expert Rev Anti Infect Ther. 2019; 17(3): 145-157. doi:10.1080/14787210.2019.1577731
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.
Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) [published online ahead of print, 2020 Jul 27]. JAMA Cardiol. 2020; 10.1001/jamacardio.2020.3557. doi:10.1001/jamacardio.2020.3557
Zaidel EJ, Forsyth CJ, Novick G, Marcus R, Ribeiro ALP, Pinazo M-J, et al.. COVID-19: Implications for People with Chagas Disease. Global Heart. 2020; 15(1): 69. DOI: http://doi.org/10.5334/gh.891
Zaidel EJ, Wyss Quintana FS, Sosa Liprandi Á, et al. Hidroxicloroquina. Mensajes desde la cardiología en tiempos de pandemia por coronavirus [Hydroxychloroquine. Cardiology's viewpoint in times of coronavirus pandemic]. Medicina (B Aires). 2020; 80(3): 271-274.
Roubille C, Richer V, Starnino T, et al. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2015; 74(3): 480-489. doi:10.1136/annrheumdis-2014-206624
Zaroff JG, Cheetham TC, Palmetto N, et al. Association of Azithromycin Use With Cardiovascular Mortality. JAMA Netw Open. 2020; 3(6): e208199. doi:10.1001/jamanetworkopen.2020.8199
Israel Molina, Milena S. Marcolino, Magda C. Pires, et al. Chagas disease and SARS-CoV-2 coinfection does not lead to worse in-hospital outcomes: results from the Brazilian COVID-19 Registry https://www.medrxiv.org/content/10.1101/2021.03.22.21254078v1 doi: https://doi.org/10.1101/2021.03.22.21254078
Li J, Huang DQ, Zou B, et al. Epidemiology of COVID-19: A Systematic Review and Meta-analysis of Clinical Characteristics, Risk factors and Outcomes [published online ahead of print, 2020 Aug 13]. J Med Virol. 2020;10.1002/jmv.26424. doi:10.1002/jmv.26424
Yang, J., et al., Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020; 94: 91-95.doi:10.1016/j.ijid.2020.03.017
Published
How to Cite
License
Copyright (c) 2021 Ezequiel José Zaidel, E. Florencia Segovia, Sebastian Nuñez, Luis C Palomino Romero, Ernesto Caliva, José Fabián Arcos Alcívar, Joaquín Perea, Matías Ariel Oliva, Lara Gheco, Luis Guillermo García Chamorro, Melisa Elfman, Horacio Germán Cestari, Ricardo Alfredo Villarreal, María Inés Sosa Liprandi, Álvaro Sosa Liprandi
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
